<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Dengue hemorrhagic fever</italic> (DHF) is any suspected dengue case that meets the following WHO criteria 
 <xref rid="pntd.0001614-World1" ref-type="bibr">[20]</xref>: (1) fever or recent history of fever, (2) any hemorrhagic manifestation, (3) platelet count of ≤100,000/mm
 <sup>3</sup>, and (4) evidence of increased vascular permeability and plasma leakage which includes: (a) hemoconcentration with a hematocrit ≥20% above the U.S. population mean for age and sex, 
 <xref rid="pntd.0001614-The1" ref-type="bibr">[21]</xref>, 
 <xref rid="pntd.0001614-Hollowell1" ref-type="bibr">[22]</xref> (b) ≥20% decline in hematocrit following volume-replacement treatment compared to baseline, (c) presence of pleural effusion or ascites detected by any imaging method, or (d) a serum protein or albumin &lt;2.5 percentile for age and sex 
 <xref rid="pntd.0001614-Pediatric1" ref-type="bibr">[23]</xref>–
 <xref rid="pntd.0001614-Lockitch1" ref-type="bibr">[25]</xref>.
</p>
